aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
09 nov. 2023 16h00 HE
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...
[Latest] Global Split Air Conditioning Systems Market Size/Share Worth USD 37.9 Billion by 2032 at a 5.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
09 nov. 2023 15h30 HE
|
Custom Market Insights
Austin, TX, USA, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Split Air Conditioning Systems Market Size, Trends and Insights By Application...
Life & Banc Split Corp. Completes Preferred Share Offering
31 oct. 2023 08h58 HE
|
Life & Banc Split Corp.
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- (TSX: LBS, LBS.PR.A) Life & Banc Split Banc Corp. (the...
Life & Banc Split Corp. Announces Successful Preferred Share Offering
18 oct. 2023 16h56 HE
|
Life & Banc Split Corp.
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Oct. 18, 2023 (GLOBE NEWSWIRE) -- (TSX: LBS, LBS.PR.A) Life & Banc Split Banc Corp. (the...
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
11 sept. 2023 08h00 HE
|
aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...
Life & Banc Split Corp. Announces Preferred Share Distribution Rate
28 août 2023 17h06 HE
|
Life & Banc Split Corp.
TORONTO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- (TSX: LBS, LBS.PR.A) Life & Banc Split Corp. (the “Fund”) announces that the preferred share (the “Preferred Shares”) distribution rate for the new...
“The Life Cycle” Podcast from Klang Games Clarifies the Most Important Questions About the Future of Mankind
06 avr. 2023 09h30 HE
|
Klang Games
BERLIN, April 06, 2023 (GLOBE NEWSWIRE) -- Klang Games, the makers behind the sandbox simulation MMO game SEED, are not only concerned with the future of mankind and the colonization of exoplanets...
Life & Banc Split Corp. Announces Extension of Term
04 avr. 2023 16h36 HE
|
Life & Banc Split Corp.
TORONTO, April 04, 2023 (GLOBE NEWSWIRE) -- (TSX: LBS, LBS.PR.A) Life & Banc Split Corp. (the “Company”) is pleased to announce that the board of directors has approved an extension of the...
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Sarcoidosis and Transitioning from Steroids to New and Investigational Therapies
20 mars 2023 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of first-in-class medicines from its...
aTyr Pharma Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
09 mars 2023 16h00 HE
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in patients with pulmonary sarcoidosis enrolling in the U.S., Europe and Japan. Phase 2 proof-of-concept study of efzofitimod in patients with SSc-ILD expected...